The Discounted Cash Flow (DCF) valuation of ABIOMED Inc (ABMD) is 138.75 USD. With the latest stock price at 381.02 USD, the upside of ABIOMED Inc based on DCF is -63.6%.
Based on the latest price of 381.02 USD and our DCF valuation, ABIOMED Inc (ABMD) is a sell. selling Abiomed stocks now will result in a potential gain of 63.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.0% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 90.38 - 332.56 | 138.75 |
| Upside | -76.3% - -12.7% | -63.6% |